论文部分内容阅读
近年脑血栓在脑梗死中所占比率增加,其中腔隙梗死约占30％。随着CT和MRI影像学诊断的发展使小梗死灶也很少漏诊。有临床症状的腔隙梗死是今后治疗的重点。目前关于腔隙梗死的治疗尚无明确定论。作者采用安全、价廉的静脉输液疗法,对尿激酶(UK)与sodium ozagrel(SO)治疗进行了临床比较。 患者为经CT或MRI诊断的腔隙梗死病例,均有运动障碍、语言障碍或意识障碍,症状出现后3d内开始治疗。UK组(n=11)给予溶栓剂UK42万U,连续静滴2d;SO组(n=23)给予抗血小板药物SO 160mg/d,静滴2周。运动障碍分0级～5级。意识按
In recent years, the proportion of cerebral thrombosis in cerebral infarction increased, of which about 30% of infarcts. With the development of CT and MRI imaging diagnosis of small infarcts rarely missed. The clinical symptoms of lacunar infarction is the focus of future treatment. The current treatment of lacunar infarction is not conclusive. The authors compared the efficacy of urokinase (UK) with sodium ozagrel (SO) in a safe and inexpensive intravenous infusion regimen. Patients with CT or MRI diagnosis of lacunar infarction cases, have dyskinesia, speech impairment or disturbance of consciousness, the symptoms appear within 3d after treatment. UK group (n = 11) was given thrombolytic agent UK4,200 U for two consecutive days; SO group (n = 23) was given anti-platelet drug SO 160mg / d for two weeks. Dyskinesia 0 to 5. Consciousness press